COST EFFECTIVENESS ANALYSIS OF A VACCINE TO PREVENT HERPES ZOSTER AND POSTHERPETIC NEURALGIA IN ITALY

被引：2
|
作者：
Coretti, S. [1 ]
Ruggeri, M. [1 ]
Codella, P. [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.1572
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIH42
引用
收藏
页码：A511 / A511
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
    Hornberger, John
    Robertus, Katherine
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 145 (05) : 317 - 325
  • [2] Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
    Rothberg, Michael B.
    Virapongse, Anunta
    Smith, Kenneth J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (10) : 1280 - 1288
  • [3] A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
    Oxman, MN
    Levin, MJ
    Johnson, GR
    Schmader, KE
    Straus, SE
    Gelb, LD
    Arbeit, RD
    Simberkoff, MS
    Gershon, AA
    Davis, LE
    Weinberg, A
    Boardman, KD
    Williams, HM
    Zhang, JHY
    Peduzzi, PN
    Beisel, CE
    Morrison, VA
    Guatelli, JC
    Brooks, PA
    Kauffman, CA
    Pachucki, CT
    Neuzil, KM
    Betts, RF
    Wright, PF
    Griffin, MR
    Brunell, P
    Soto, NE
    Marques, AR
    Keay, SK
    Goodman, RP
    Cotton, DJ
    Gnann, JW
    Loutit, J
    Holodniy, M
    Keitel, WA
    Crawford, GE
    Yeh, SS
    Lobo, Z
    Toney, JF
    Greenberg, RN
    Keller, PM
    Harbecke, R
    Hayward, AR
    Irwin, MR
    Kyriakides, TC
    Chan, CY
    Chan, ISF
    Wang, WWB
    Annunziato, PW
    Silber, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (22): : 2271 - 2284
  • [4] Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
    Pellissier, James M.
    Brisson, Marc
    Levin, Myron J.
    [J]. VACCINE, 2007, 25 (49) : 8326 - 8337
  • [5] Vaccination to prevent herpes zoster and postherpetic neuralgia
    Oxman, Michael N.
    [J]. HUMAN VACCINES, 2007, 3 (02): : 64 - 68
  • [6] Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis
    Bresse, Xavier
    Annemans, Lieven
    Preaud, Emmanuelle
    Bloch, Karine
    Duru, Gerard
    Gauthier, Aline
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (03) : 393 - 406
  • [7] Cost-effectiveness of herpes zoster vaccine: Flawed assumptions regarding efficacy against postherpetic neuralgia
    Brisson, Marc
    Pellissier, James M.
    Levin, Myron J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (11) : 1527 - 1529
  • [8] Herpes zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in New Zealand: a retrospective cohort study
    Mbinta, James F.
    Wang, Alex X.
    Nguyen, Binh P.
    Paynter, Janine
    Awuni, Prosper Mandela A.
    Pine, Russell
    Sporle, Andrew A.
    Simpson, Colin R.
    [J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 31
  • [9] Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany
    Bernhard Ultsch
    Ingrid Köster
    Thomas Reinhold
    Anette Siedler
    Gérard Krause
    Andrea Icks
    Ingrid Schubert
    Ole Wichmann
    [J]. The European Journal of Health Economics, 2013, 14 : 1015 - 1026
  • [10] Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany
    Ultsch, Bernhard
    Koester, Ingrid
    Reinhold, Thomas
    Siedler, Anette
    Krause, Gerard
    Icks, Andrea
    Schubert, Ingrid
    Wichmann, Ole
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2013, 14 (06): : 1015 - 1026
12345